Thomas H. Lee Partners and Frazier Healthcare Partners Acquire Adare Pharmaceuticals
September 22, 2020
Thomas H. Lee Partners and Frazier Healthcare Partners have acquired Adare Pharmaceuticals (to be rebranded Adare Pharma Solutions) from TPG Capital. The deal includes Adare’s CDMO, pharmaceutical technology and microbiome businesses while TPG retained rights to an EoE product spun into a separate entity; terms were not disclosed.
- Targets
- Adare Pharmaceuticals (Adare Pharma Solutions)
- Sellers
- TPG Capital
- Industry
- Pharmaceuticals
- Location
- Pennsylvania, United States
- Transaction Type
- Buyout
Explore More
Related Acquisitions
-
ADVI Health Acquires Partnership for Health Analytic Research (PHAR)
August 23, 2024
Healthcare Services
ADVI Health has acquired Partnership for Health Analytic Research (PHAR), a global HTA and HEOR consultancy with roughly 20 years of experience delivering real-world evidence, patient registries, and value strategy research for biopharma clients. The acquisition expands ADVI’s Strategic Analytics, Value and Economics (SAVEs) capabilities—bringing PHAR’s HEOR and implementation science expertise into ADVI’s market access and commercialization services.
-
Frazier Healthcare Partners Acquires BioMatrix Specialty Infusion Pharmacy
June 25, 2024
Healthcare Services
Frazier Healthcare Partners has completed the acquisition of BioMatrix Holdings, LLC (BioMatrix Specialty Infusion Pharmacy), a Plantation, Florida–based provider of home-based specialty infusion services. Financial terms were not disclosed; Frazier is partnering with industry executives Ted and Kathee Kramm to expand BioMatrix’s national footprint and accelerate growth through new locations and add-on acquisitions.
-
Adare Pharma Solutions Acquires Frontida BioPharm
December 1, 2021
Pharmaceuticals
Adare Pharma Solutions, a PE-backed contract development and manufacturing organization (CDMO), has acquired Frontida BioPharm, a vertically integrated CDMO focused on oral formulations. The deal expands Adare’s capabilities—including high-potency compound handling and packaging services—and increases its manufacturing footprint; Adare is backed by Thomas H. Lee Partners and Frazier Healthcare Partners.
-
Frazier Healthcare Partners Acquires 50% Stake in CSafe Global from Thomas H. Lee Partners
January 6, 2021
Logistics & Distribution
Frazier Healthcare Partners has acquired a 50% stake in CSafe Global from Thomas H. Lee Partners. CSafe, headquartered in Dayton, Ohio, is a provider of cold chain shipping solutions for pharmaceutical and life sciences customers; THL will remain a partner alongside Frazier to support the company's next phase of growth. Terms of the transaction were not disclosed.
-
Frazier Healthcare Partners Acquires EPTAM Precision Solutions
January 22, 2020
Manufacturing
Frazier Healthcare Partners acquired EPTAM Precision Solutions from New Heritage Capital in a transaction that closed in December 2019; terms were not disclosed. Frazier named Operating Partner Mark Kemp as CEO and plans to accelerate EPTAM's growth and expand its precision manufacturing capabilities for medical device and other high-precision end markets.
-
Midatech Pharma to Acquire DARA BioSciences
June 4, 2015
Pharmaceuticals
Midatech Pharma PLC entered into a merger agreement to acquire DARA BioSciences, with DARA shareholders receiving Midatech ordinary shares via ADRs and a contingent value right (CVR). The deal gives Midatech a U.S. commercial footprint and an expanded oncology supportive-care portfolio; closing was expected in Q3/Q4 2015 subject to customary conditions and ADR listing.
Build a buyer list for your deal
Find active buyers from recent acquisition patterns and move straight into outreach.